Irvine, California – October 8, 2019 –At this week’s AAO, the leading ophthalmology conference worldwide, experts can learn how a new navigated laser platform brings a level of digital guidance to retina care which is already state-of-the-art in front-of-the eye treatments. The Navilas® 577s is a retina laser with integrated eye tracking technology, a transparent workflow and documentation which proves in more and more clinics and teaching hospitals to be the next generation digital laser platform and to contribute to the revival of laser in posterior segment applications.
At AAO booth 2055, user experiences with the navigated laser are presented in a case poster exhibition, while live demos allow for hands-on experience with the Navilas® 577s Laser System.
Presented cases highlight how the Navilas® laser platform can have advantages over conventional or pattern laser systems in main posterior segment applications:
- Precise focal treatments, e.g. of macular edema, thanks to targeting via the overlay of diagnostic images
- Fast and comfortable peripheral treatments, e.g. of retinal tears, through pre-planning of equidistant laser spots and computer-guided laser delivery
- Easy-to-control subthreshold treatments, e.g. of central serous chorioretinopathy, through confluent laser delivery and transparent documentation of “invisible” laser treatment
These cases are complemented by what users of Navilas® 577s, the 2nd generation navigated laser, are saying:
Dr. Robin Ross, Global Retina Institute, Arizona, USA: "With this navigated laser, first time in my 20+ years career that I had a full PRP in one eye, while the patient graded the pain as a 1 and asked to have the other eye treated same day. The diminished pain experience improves the odds of follow-up within our patient population. Our team really feels with the Navilas® we give people a fighting chance at saving sight.”
Dr. Lars Freisberg, Tulsa Retina Consultants, Oklahoma, USA: “Because treatment with Navilas® is more comfortable for patients, they more often return for their therapy which has significantly increased the number of PRP treatments we perform. Therefore, Navilas® 577s was a worthwhile investment also from the financial point of view as the system basically paid itself within the first year.”
Dr. Pradeep Prasad, Harbor-UCLA, California, USA: "A challenge when using subthreshold laser is that you don't have visual feedback. With Navilas® documentation, it's really transparent where you applied the laser."
About OD-OS: OD-OS GmbH is a privately-held medical device company founded in 2008 with offices in Teltow, Germany, and Irvine, CA. https://www.od-os.com